These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 37392341)

  • 1. Endothelium dysfunction and thrombosis in COVID-19 with type 2 diabetes.
    Li M; Wu X; Shi J; Niu Y
    Endocrine; 2023 Oct; 82(1):15-27. PubMed ID: 37392341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation.
    Wang C; Yu C; Jing H; Wu X; Novakovic VA; Xie R; Shi J
    Front Cell Infect Microbiol; 2022; 12():861703. PubMed ID: 35449732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art.
    Dimakakos E; Gomatou G; Catalano M; Olinic DM; Spyropoulos AC; Falanga A; Maraveyas A; Liew A; Schulman S; Belch J; Gerotziafas G; Marschang P; Cosmi B; Spaak J; Syrigos K;
    Anticancer Res; 2022 Jul; 42(7):3261-3274. PubMed ID: 35790272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis.
    Dybowska M; Wyrostkiewicz D; Opoka L; Lewandowska K; Sobiecka M; Tomkowski W; Szturmowicz M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [COVID-19 and thromboprophylaxis: Recommendations for our clinical practice in Primary Care].
    Piera Carbonell A; Frías Vargas M; García Vallejo O; García Lerín A; Cabrera Ferriols MA; Peiró Morant J; Carrasco Carrasco E;
    Semergen; 2020 Oct; 46(7):479-486. PubMed ID: 33046353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study.
    Muñoz-Rivas N; Abad-Motos A; Mestre-Gómez B; Sierra-Hidalgo F; Cortina-Camarero C; Lorente-Ramos RM; Torres-Rubio P; Arranz-García P; Franco-Moreno AI; Gómez-Mariscal E; Mauleón-Fernández C; Alonso-García S; Rogado J; Saez-Vaquero T; Such-Diaz A; Ryan P; Moya-Mateo E; Martín-Navarro JA; Hernández-Rivas JA; Torres-Macho J; Churruca J;
    Thromb Res; 2021 Mar; 199():132-142. PubMed ID: 33503547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
    Obi AT; Barnes GD; Napolitano LM; Henke PK; Wakefield TW
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):23-35. PubMed ID: 32916371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus.
    Valencia I; Lumpuy-Castillo J; Magalhaes G; Sánchez-Ferrer CF; Lorenzo Ó; Peiró C
    Cardiovasc Diabetol; 2024 Feb; 23(1):75. PubMed ID: 38378550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 coagulopathy - what should we treat?
    Chowdary P
    Exp Physiol; 2022 Jul; 107(7):749-758. PubMed ID: 35733235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombosis in COVID 2022: An Updated Narrative Review of Current Literature and Inpatient Management.
    Muthiah A; Ohnigian S; Reagan JL; Hsu A
    R I Med J (2013); 2022 Aug; 105(6):36-40. PubMed ID: 35881999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboprophylaxis Outcome in Childhood SARS-CoV-2 Infection: A Single-Center Experience.
    Karimi M; Sanaei Dashti A; Haghpanah S; Mansoori Y; Zarei T; Amanati A; Bordbar M
    J Pediatr Hematol Oncol; 2023 Jan; 45(1):e97-e102. PubMed ID: 36162044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological mechanisms of thrombosis in acute and long COVID-19.
    Jing H; Wu X; Xiang M; Liu L; Novakovic VA; Shi J
    Front Immunol; 2022; 13():992384. PubMed ID: 36466841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review.
    Cryer MJ; Farhan S; Kaufmann CC; Jäger B; Garg A; Krishnan P; Mehran R; Huber K
    Clin Appl Thromb Hemost; 2022; 28():10760296221074353. PubMed ID: 35068227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases.
    Acanfora D; Acanfora C; Ciccone MM; Scicchitano P; Bortone AS; Uguccioni M; Casucci G
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis.
    Kelliher S; Weiss L; Cullivan S; O'Rourke E; Murphy CA; Toolan S; Lennon Á; Szklanna PB; Comer SP; Macleod H; Le Chevillier A; Gaine S; O'Reilly KMA; McCullagh B; Stack J; Maguire PB; Ní Áinle F; Kevane B
    J Thromb Haemost; 2022 Apr; 20(4):1008-1014. PubMed ID: 35102689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [SARS-CoV-2 infection as a thrombo-inflammatory endothelial disease].
    Samaniego F; Conte G
    Rev Med Chil; 2020 Oct; 148(10):1467-1474. PubMed ID: 33844717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-associated coagulopathy and antithrombotic agents-lessons after 1 year.
    Leentjens J; van Haaps TF; Wessels PF; Schutgens REG; Middeldorp S
    Lancet Haematol; 2021 Jul; 8(7):e524-e533. PubMed ID: 33930350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous Thrombosis and SARS-CoV-2.
    Zdanyte M; Rath D; Gawaz M; Geisler T
    Hamostaseologie; 2022 Aug; 42(4):240-247. PubMed ID: 34879422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19-induced coagulopathy: Experience, achievements, prospects.
    Dubey L; Dorosh O; Dubey N; Doan S; Kozishkurt O; Duzenko O; Kozlova O; Ievtukh V; Ladny JR; Pruc M; Szarpak L; Pukach J
    Cardiol J; 2023; 30(3):453-461. PubMed ID: 36588310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of protocol-based high-intensity pharmacological thromboprophylaxis on thrombotic events in critically ill COVID-19 patients.
    Atallah B; Sadik ZG; Salem N; El Nekidy WS; Almahmeed W; Park WM; Cherfan A; Hamed F; Mallat J
    Anaesthesia; 2021 Mar; 76(3):327-335. PubMed ID: 33047335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.